• हिन्दी
  • ગુજરાતી
  • বাংলা
  • తెలుగు
  • मराठी
  • ಕನ್ನಡ
  • money9
  • Insurance
  • Saving
  • Mutual Funds
  • Mirae Asset MF
  • Breaking Briefs
downloadDownload The App
Close
  • Home
  • Videos
  • Podcast
  • Banking
  • Bulletin
  • Gold
  • Healthcare
  • Real Estate
  • Tax
  • Travel
  • Survey 2023
  • Survey Report
  • Breaking Briefs
  • Insurance
  • Savings
  • Loan
  • Crypto
  • Investment
  • Mutual Funds
  • Real Estate
  • Tax
  • Exclusive
  • Home » Sharekhan » Page 2

Sharekhan

  • Earnings Review

    What should you do with Tech Mahindra stock post Q1 results? Here’s what brokerages say

    Most brokerages revised their earnings estimate upwards as Tech Mahindra delivered on all fronts be it margin, capital allocation, deals & revenue

  • Stocks Recommendation

    Should you buy Maruti Suzuki post Q1 result?

    Maruti Suzuki is well placed amongst OEMs despite concerns over raw material inflation and supply shortages

  • IPO Alert

    Rolex Rings IPO opens today; should you subscribe?

    The Indian bearing industry accounts for less than 4% of the global bearing market, though its share is expected to grow over the medium to long-term

  • Stocks to Buy

    Should you buy or hold HUL shares post Q1 results?

    According to Motilal Oswal, the company continues to strengthen the key drivers of its success in India over the last decade

  • Stocks to buy

    Asset light model has made analysts upbeat on this hotel stock

    Indian Hotels said that in FY18, management contract hotels formed around 33% of its overall portfolio, which has now increased to 46%

  • Videos

    Sharekhan sees over 20% upside in this smallcap firm; should you buy?

    The stock is trading at a reasonable valuation of 21 times and 18 times its FY2022E and FY2023E earnings

  • Markets

    Should you invest in TCS shares post-Q1 results?

    TCS's overall revenue stood at Rs 45,411 crore, up 18.5% as compared to the year-ago period and 3.9% higher than the March quarter

  • Markets

    This newly listed firm doubled investors' money in 8 months

    The company is an established player globally in sterile injectables and is one of the fastest-growing generic injectable companies

  • Money Spinners

    Multibaggers: Check out Gaurav Dua's 'formula'

    Gaurav Dua, Head-capital market strategy, Sharekhan by BNP Paribas, feels there is so much to learn in the equity markets on a daily basis

  • Markets

    This stock jumped 195% in 1 year; should you invest?

    Sharekhan believes that the company will be one of the key beneficiaries of the rising demand for Indian home textiles in export markets

  • ←
  • 1
  • 2
  • 3
  • 4
  • 5
  • →

Latest

  • 1. Know the correct way to get KYC done!
  • 2. Why health insurance claim gets rejected?
  • 3. Power to Respond!
  • 4. What is Asset Under Management?
  • 5. No Worries on Medical Expenses!
  • Trending Stories

  • DGCA प्रमुख ने सुचारू उड़ान संचालन सुनिश्चित करने के लिए पायलटों से मांगा सहयोग
  • रेपो दर में कटौती से घर के लिए कर्ज होगा सस्ता, मांग बढ़ेगी: रियल एस्टेट
  • मीशो के 5,421 करोड़ रुपये के आईपीओ को दूसरे दिन मिला 7.97 गुना अभिदान
  • इंडिगो को अगले साल 10 फरवरी तक उड़ान संचालन पूरी तरह बहाल होने की उम्मीद
  • Indigo की 200 से ज्यादा फ्लाइट रद्द, हजारों पैसेंजर फंसे
  • TV9 Sites

  • TV9 Hindi
  • TV9Telugu.com
  • TV9 Marathi
  • TV9 Gujarati
  • TV9 Kannada
  • TV9 Bangla
  • TV9 English
  • News9 Live
  • Trends9
  • Tv9tamilnews
  • Assamtv9
  • Malayalamtv9
  • Money9 Sites

  • Money9 Hindi
  • Money9 English
  • Money9 Marathi
  • Money9 Telugu
  • Money9 Gujarati
  • Money9 Kannada
  • Money9 Bangla
  • Money9live
  • Topics

  • Insurance
  • Savings
  • Loan
  • Stocks
  • Mutual Funds
  • Real Estate
  • Tax
  • Crypto
  • Exclusive
  • Follow us

  • FaceBook
  • Twitter
  • Youtube
  • Instagram
  • Linkedin
  • Download App

  • play_store
  • App_store
  • Contact Us
  • About Us
  • Advertise With Us
  • Privacy & Cookies Notice
  • Complaint Redressal
  • Copyright © 2025 Money9. All rights reserved.
  • share
  • Facebook
  • Twitter
  • Whatsapp
  • LinkedIn
  • Telegram
close